0000000000678910

AUTHOR

Wojciech Milejski

0000-0002-6366-9073

showing 2 related works from this author

Real-Life Outcomes of Coronary Bifurcation Stenting in Acute Myocardial Infarction (Zabrze–Opole Registry)

2021

Percutaneous coronary intervention (PCI) of bifurcation lesions is a technical challenge associated with high risk of adverse events, especially in primary PCI. The aim of the study is to analyze long-term outcomes after PCI for coronary bifurcation in acute myocardial infarction (AMI). The outcome was defined as the rate of major adverse cardiac event related to target lesion failure (MACE-TLF) (death-TLF, nonfatal myocardial infarction-TLF and target lesion revascularization (TLR)) and the rate of stent thrombosis (ST). From 306 patients enrolled to the registry, 113 were diagnosed with AMI. In the long term, AMI was not a risk factor for MACE-TLF. The risk of MACE-TLF was dependent on th…

Target lesionmedicine.medical_specialtymedicine.medical_treatmentacute myocardial infarctionCulpritArticlemedicine.arteryInternal medicinemedicineDiseases of the circulatory (Cardiovascular) systemPharmacology (medical)cardiovascular diseasesMyocardial infarctionGeneral Pharmacology Toxicology and PharmaceuticsRisk factoracute myocardial infarction; coronary bifurcation; percutaneous coronary intervention; target lesion failureAdverse effectcoronary bifurcationbusiness.industrypercutaneous coronary interventionPercutaneous coronary interventionmedicine.diseaseRC666-701Right coronary arteryConventional PCICardiologytarget lesion failurebusinessJournal of Cardiovascular Development and Disease
researchProduct

Management of bleeding in patients hospitalized in the intensive cardiac care unit: expert opinion of the Association of Intensive Cardiac Care and S…

2019

ABSTRACT Nowadays, the intensive cardiac care unit (ICCU) provides care for patients with acute coronary syndrome, acute and exacerbated chronic heart failure, cardiogenic shock, sudden cardiac arrest, electrical storm, as well as with indications for urgent cardiac surgical treatment. Most of these patients require the use of 1, 2, or frequently even 3 drugs that act on the blood coagulation pathway. While antithrombotic drugs prevent thromboembolic events, they are associated with a higher risk of bleeding. In this population of patients, bleeding may often have a worse impact on prognosis than the primary disease. In this expert opinion of the Association of Intensive Cardiac Care, we pr…

Malemedicine.medical_specialtyAcute coronary syndromePopulationCardiologyHemorrhagePharmacotherapyFibrinolytic AgentsRisk FactorsThromboembolismAntithromboticmedicineHumansIn patientCardiac Surgical ProceduresIntensive care medicineeducationSocieties MedicalAgedAged 80 and overeducation.field_of_studybusiness.industryCardiogenic shockDisease ManagementSudden cardiac arrestmedicine.diseaseIntensive Care UnitsHeart failureFemalePolandmedicine.symptomCardiology and Cardiovascular MedicinebusinessKardiologia polska
researchProduct